Menu
Search
|

Menu

Close
X

Anika Therapeutics Inc ANIK.OQ (NASDAQ Stock Exchange Global Select Market)

52.17 USD
-5.54 (-9.60%)
As of 3:00 PM EST
chart
Previous Close 57.71
Open 49.02
Volume 72,834
3m Avg Volume 29,504
Today’s High 52.46
Today’s Low 45.97
52 Week High 68.57
52 Week Low 41.64
Shares Outstanding (mil) 14.66
Market Capitalization (mil) 846.13
Forward P/E 27.36
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY17
113
FY16
103
FY15
93
EPS (USD)
FY17
2.109
FY16
2.154
FY15
2.006
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
27.36
34.59
Price to Sales (TTM)
vs sector
7.46
8.08
Price to Book (MRQ)
vs sector
3.22
5.24
Price to Cash Flow (TTM)
vs sector
31.37
25.98
Total Debt to Equity (MRQ)
vs sector
--
15.60
LT Debt to Equity (MRQ)
vs sector
--
12.18
Return on Investment (TTM)
vs sector
12.70
13.67
Return on Equity (TTM)
vs sector
13.09
15.40

EXECUTIVE LEADERSHIP

Joseph Darling
President, Since 2017
Salary: --
Bonus: --
Charles Sherwood
Chief Executive Officer, Director, Since 2017
Salary: $601,586.00
Bonus: $496,308.00
Sylvia Cheung
Chief Financial Officer, Treasurer, Secretary, Since 2013
Salary: $346,942.00
Bonus: $171,736.00
Edward Ahn
Chief Technology and Strategy Officer, Since 2014
Salary: $315,675.00
Bonus: $156,259.00
Richard Hague
Chief Commercial Officer, Since 2015
Salary: $315,000.00
Bonus: $127,575.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

32 Wiggins Ave
BEDFORD   MA   01730-2315

Phone: +1781.4579000

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.

SPONSORED STORIES